GrayBug Investors

28 investors on Angel Roster list GrayBug in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Israel and China.

Investors are matched on the company name in their portfolio, so companies that share the name GrayBug can appear together.

Investors listed
28
With verified email
68%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 28 GrayBug investors

The most complete profiles first. Showing 28 of 28.

  • Adam GreeneVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Ben ScruggsVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 46 more

    Verified email available

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Douglas ReedVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 46 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jeff TerrellVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Verified email available

  • John CrumplerVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 47 more

    Verified email available

  • Narendra NayakVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Nicholas BishopVerified

    Hedge Fund, Venture Capital, Investment Partner · United States

    Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information Services

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Bill CollierVerified

    Government Office · United States

    Health CareE-commerceCybersecurityWomen Founded

    Portfolio: PathSensors, RedOwl, Nuo Therapeutics, Zeuss and 59 more

    Verified email available

  • Frank GloverVerified

    Government Office · United States

    Health CareE-commerceCybersecurityWomen Founded

    Portfolio: PathSensors, RedOwl, Nuo Therapeutics, Zeuss and 59 more

    Verified email available

  • Howie FurstVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Kevin BergVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Contact details available

  • Michael DialVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Robert MorffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Verified email available

  • Vincent MelletVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Christy ShafferVerified

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    SeedHealth CareCustomer ServiceWomen FoundedEnterprise Software

    Portfolio: Spyryx Biosciences, GrayBug, G1 Therapeutics, Clearside Biomedical and 3 more

    Verified email available

  • James Flynn

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information Services

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 80 more

    Contact details available

  • Kseniya Simpson, PhD

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Avi Kometz

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

Frequently asked questions

How many GrayBug investors are on Angel Roster?

Angel Roster lists 28 GrayBug investors. 19 of them (68%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (17), Private Equity Firms (16) and Hedge Funds (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do GrayBug investors invest in?

Among those that list a stage, the most common are Seed (11), Series A (5) and Series B (4).

Where are GrayBug investors based?

Most are based in the United States (25), Israel (2) and China (1).

Which companies have GrayBug investors backed?

The most-backed portfolio companies among them are Acutus Medical (18), Nuvation Bio (18), Syros Pharmaceuticals (18), Keros Therapeutics (10) and AnchorDx (10).

How do I contact GrayBug investors?

Create a free Angel Roster account to search and filter all 28, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.